Latest European Association of Urology Stories
BALTIMORE, July 30, 2014 /PRNewswire-USNewswire/ -- The American Urological Association (AUA) today issued a statement in response to the new Institute of Medicine (IOM) July 29 report, "Graduate
CHARLOTTE, N.C., May 27, 2014 /PRNewswire/ -- Medical device manufacturer SonaCare Medical reports continuing strong European sales as well as a positive outlook in light of official guideline
NEW YORK, April 28, 2014 /PRNewswire/ -- Elsevier [http://www.elsevier.com ], world-leading provider of scientific, technical and medical information products and services,
Enterocystoplasty is a good surgical option with a low rate of severe complications in the treatment of children who were born with developmental abnormalities of the genitourinary system.
A new study reveals that in the prediction of treatment outcome for castration-resistant prostate cancer, a change in circulating tumor cells detection might be more accurate than the change in prostate-specific antigen levels.
The initial study results of the Zometa European Study (ZEUS) showed no difference in the incidence of bone metastases between the Zometa group and control arm, said Prof. Manfred Wirth during the closing and fourth plenary session of the 28th Annual EAU Congress which ends today.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumors might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC).
Small kidney tumors have an aggressive potential and should be treated.
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer.